Skip to main content
OpenTrials
Completed

NCT Number: NCT01247181

Cameroon Mobile Phone SMS Trial

The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adherence Acquired Immunodeficiency Syndrome Behavior Blood-Borne Infections Communicable Diseases Genital Diseases HIV HIV Infections Health Behavior Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Patient Acceptance of Health Care Patient Compliance RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Treatment Adherence and Compliance Urogenital Diseases Virus Diseases

Age range

21 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yaounde Central Hospital Accredited Treatment Centre

Yaoundé, Centre Region, Cameroon

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • On HAART for at least 1 month
  • 21 years or more
  • Owns a mobile phone
  • Can read text messages

Exclusion criteria

  • On HAART for less than 1 month
  • Aged less than 21 years

Treatment and study plan

Mobile phone text message

Other

Weekly message with motivational content

Other names: SMS, Texto, Text message

Usual Care

Other

Usual care provided at clinic

Other names: Routine care

Primary outcomes

  1. Adherence

    Time frame: Change from baseline at 6 months

    Measured using the Visual Analogue Scale, Self Report and Pharmacy Refill Data

Secondary outcomes

  1. Weight

    Time frame: Change from baseline at 6 months

  2. Body Mass Index

    Time frame: Change from baseline at 6 months

  3. CDC classification

    Time frame: Change from baseline at 6 months

  4. WHO Classification

    Time frame: Change from baseline at 6 months

  5. Mortality

    Time frame: 6 months

    All cause mortality

  6. CD4 count

    Time frame: Change from baseline at 6 months

  7. Viral load

    Time frame: Change from baseline at 6 months

  8. Quality of life

    Time frame: Change from baseline at 6 months

    Measured using the SF-12 quality of life form

Sponsors and collaborators

Lead sponsor

Yaounde Central Hospital

Other Gov

Collaborators

  • CIHR Canadian HIV Trials Network

Registry information

Official study title

Improving Adherence to HAART Using Mobile Phone Text Messages

Acronym: CAMPS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Nov 24, 2010
Registry last updated
Sep 8, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.